|
Tagant 40 mg tbl flm 112x1x40 mg (blis.Al-OPA/Al/PVC - jednotk.bal.)
40 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
Tagant 40 mg tbl flm 112x40 mg (blis.Al-OPA/Al/PVC)
40 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
Tagant 40 mg tbl flm 112x40 mg (fľ.HDPE)
40 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
Tagant 80 mg tbl flm 56x1x80 mg (blis.Al-OPA/Al/PVC - jednotk.bal.)
80 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
Tagant 80 mg tbl flm 56x80 mg (blis.Al-OPA/Al/PVC)
80 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
Tagant 80 mg tbl flm 56x80 mg (fľ.HDPE)
80 mg
|
Filmom obalená tableta |
L02BB04
|
Egis Pharmaceuticals PLC |
—
|
|
TAMOXIFEN Sandoz 10 mg tbl 100x10 mg (blis.PVC/PVDC/Al)
10 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 10 mg tbl 100x10 mg (liek.PP)
10 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 10 mg tbl 30x10 mg (blis.PVC/PVDC/Al)
10 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 10 mg tbl 30x10 mg (liek.PP)
10 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 20 mg tbl 100x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 20 mg tbl 100x20 mg (liek.PP)
20 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 20 mg tbl 30x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TAMOXIFEN Sandoz 20 mg tbl 30x20 mg (liek.PP)
20 mg
|
Tableta |
L02BA01
|
Sandoz Pharmaceuticals d.d. |
—
|
|
TATICA 250 mg tbl flm 112x250 mg (blis. Al/OPA/Al/PVC)
250 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 250 mg tbl flm 112x250 mg (blis. Al/PVC/PE/PVDC)
250 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 250 mg tbl flm 120x250 mg (blis. Al/OPA/Al/PVC)
250 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 250 mg tbl flm 120x250 mg (blis. Al/PVC/PE/PVDC)
250 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 500 mg tbl flm 56x500 mg (blis. Al/OPA/Al/PVC)
500 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 500 mg tbl flm 56x500 mg (blis. Al/PVC/PE/PVDC)
500 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 500 mg tbl flm 60x500 mg (blis. Al/OPA/Al/PVC)
500 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
TATICA 500 mg tbl flm 60x500 mg (blis. Al/PVC/PE/PVDC)
500 mg
|
Filmom obalená tableta |
L02BX03
|
Egis Pharmaceuticals PLC |
—
|
|
Toletate imp sip 1x10,72 mg (striek.inj.napl.plast.)
11,25 mg
|
Implantát v naplnenej injekčnej striekačke (Implantát naplnený v injekčnej striekačke - platné do okt2020) |
L02AE02
|
Zentiva, k.s. |
—
|
|
Toletate imp sip 2x10,72 mg(striek.inj.napl.plast.)
11,25 mg
|
Implantát v naplnenej injekčnej striekačke (Implantát naplnený v injekčnej striekačke - platné do okt2020) |
L02AE02
|
Zentiva, k.s. |
—
|